Oslo, Norway, and Edison, NJ—Vitamin K supplementation may be an option to inhibit vascular micro-calcification, according to a new review paper published in The European Journal of Preventive Cardiology. The review paper is the result of an INTRICARE grant awarded to NattoPharma’s International Research Network by the European Union. The...
Oslo, Norway and Edison, NJ--A paper, titled “Role of Vascular Smooth Muscle Cell Phenotypic Switching and Calcification in Aortic Aneurysm Formation: Involvement of Vitamin K-Dependent Processes” published in the journal Arteriosclerosis, Thrombosis, and Vascular Biology addresses the role of vitamin K and vitamin K-dependent proteins (VKDPs) that are involved in...
Leuven, Belgium—Vitamin K2 could be vital to heart health maintenance, according to a new study published in Journal of the American Heart Association. According to the study, stiffening and calcification of the large arteries are major forerunners of cardiovascular complications. Matrix Gla Protein (MGP) inhibits this calcification, but it requires...
OSLO, NORWAY, EDISON, NJ—A new study on K2 deficiency in children was published by Nutrients, an international, peer-reviewed journal for studies related to human nutrition. “The epidemiological evidence indicates a disturbing growth in the number of cases of low-energy fractures in healthy children and adolescents. There are multiple risk factors...
Oslo, Norway and Edison, NJ -Cheese is good for your heart health. And a new paper, "Menaquinone Content of Cheese," published in Nutrients and conducted at VitaK, Maastricht University in the Netherlands, examines the Vitamin K2 content of cheeses and other foods. It shows strong evidence that cheese has cardio-protective...
OSLO, Norway and Metuchen, NJ – NattoPharma is launching at SupplySide West next week a full-spectrum vitamin K2 it calls the result of a proprietary technological breakthrough providing menaquinones (MK) 6, 7, 8 and 9, a range of isomers vital for cardiovascular health. “NattoPharma has driven the creation of the...
OSLO, Norway — NattoPharma Group, maker of MenaQ7, reported accelerated interest in the branded vitamin K2 and said it is poised to take off because demand is there and global systems are now in place for greater efficiencies and scale. First half 2017 revenues rose by 18.6% to $3.84 million, which...
Oslo, Norway and Metuchen, NJ — NattoPharma, a researcher and developer of vitamin K2 products, has been awarded a grant by the Norwegian Research Council. The grant will be used to fund a 4-year project documenting how the absence or presence of vitamin K2, MK7 effects the metabolism of calcium...
Metuchen, NJ — A highly competitive ITN research grant from European Commission’s research program Horizon 2020 has been awarded to NattoPharma’s International Research Network coordinated by Queen Mary University of London. The partnership is comprised of four other highly ranked research university departments in Europe [University College Dublin (part of...
